Table 4 Perception of pharmacists regarding their involvement in medicines management (N = 396)
Perceptions | Education | Agree | Disagree | P-Value | Type | Agree | Disagree | P-Value | Experience | Agree | Disagree | P-Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacists should increase their involvement in medicines management | B/M Pharm | 45 (11.4%) | 42 (10.6%) | 0.000* | State funded | 135 (34.1%) | 64 (16.2%) | 0.028 | < 5 years | 54 (13.6%) | 14 (3.5%) | 0.000* |
Pharm.D | 229 (57.8%) | 66 (16.7%) | Private | 153 (38.6%) | 44 (11.1%) | 5–10 years | 182 (46.0%) | 54 (13.6%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 52 (13.1%) | 40 (10.1%) | ||||
Current state or private funding does not support collaborative work between pharmacists and clinicians in medicines management | B/M Pharm | 75 (18.9%) | 12 (3.0%) | 0.004 | State funded | 181 (45.7%) | 18 (4.5%) | 0.025 | < 5 years | 60 (15.2%) | 8 (2.0%) | 0.004 |
Pharm.D | 282 (71.2%) | 13 (3.3%) | Private | 190 (48%) | 7 (1.8%) | 5–10 years | 229 (57.8%) | 7 (1.8%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 82 (20.7%) | 10 (2.5%) | ||||
Other than dispensing prescriptions, pharmacists are on the periphery of the core healthcare team | B/M Pharm | 69 (17.4%) | 18 (4.5%) | 0.000* | State funded | 189 (47.7%) | 10 (2.5%) | 0.804 | < 5 years | 67 (16.9%) | 1 (0.3%) | 0.000* |
Pharm.D | 292 (73.7%) | 3 (0.8%) | Private | 186 (47%) | 11 (2.8%) | 5–10 years | 230 (58.1%) | 6 (1.5%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 78 (19.7%) | 14 (3.5%) | ||||
Clinicians do not want pharmacists to provide medicines management services | B/M Pharm | 63 (15.9%) | 24 (6.1%) | 0.000* | State funded | 163 (41.2%) | 36 (9.1%) | 0.006 | < 5 years | 58 (14.6%) | 10 (2.5%) | 0.000* |
Pharm.D | 273 (68.9%) | 22 (5.6%) | Private | 180 (45.5%) | 17 (4.3%) | 5–10 years | 217 (54.8%) | 19 (4.8%) | ||||
Overseas | 7 (1.8%) | 7 (1.8%) | – | – | – | > 10 years | 68 (17.2%) | 24 (6.1%) | ||||
Patients would not subscribe to enhanced pharmacy practice services | B/M Pharm | 38 (9.6%) | 49 (12.4%) | 0.000* | State funded | 156 (39.4%) | 43 (10.9%) | 0.002 | < 5 years | 66 (16.7%) | 2 (0.5%) | 0.000* |
Pharm.D | 281 (71.0%) | 14 (3.5%) | Private | 177 (44.7%) | 20 (5.1%) | 5–10 years | 219 (55.3%) | 17 (4.3%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 48 (12.1%) | 44 (11.1%) | ||||
Medicines management by implication calls the clinician’s judgment into question | B/M Pharm | 87 (22%) | 0 (0%) | 0.000* | State funded | 181 (45.7%) | 18 (4.5%) | 0.031 | < 5 years | 59 (14.9%) | 9 (2.3%) | 0.021 |
Pharm.D | 250 (63.1%) | 45 (11.4%) | Private | 165 (41.7%) | 32 (8.1%) | 5–10 years | 199 (50.2%) | 37 (9.3%) | ||||
Overseas | 9 (2.3%) | 5 (1.3%) | – | – | – | > 10 years | 88 (22.2%) | 4 (1.0%) | ||||
Medicines management challenges the clinician’s authority | B/M Pharm | 60 (15.2%) | 27 (6.8%) | 0.051 | State funded | 152 (38.4%) | 47 (11.9%) | 0.189 | < 5 years | 46 (11.6%) | 22 (5.6%) | 0.478 |
Pharm.D | 217 (54.8%) | 78 (19.7%) | Private | 139 (35.1%) | 58 (14.6%) | 5–10 years | 177 (44.7%) | 59 (14.9%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 68 (17.2%) | 24 (6.1%) | ||||
This enhanced clinical practice de-skills the clinicians/ practitioners | B/M Pharm | 48 (12.1%) | 39 (9.8%) | 0.000* | State funded | 154 (38.9%) | 45 (11.4%) | 0.000 | < 5 years | 62 (15.7%) | 6 (1.5%) | 0.000* |
Pharm.D | 272 (68.7%) | 23 (5.8%) | Private | 180 (45.5%) | 17 (4.3%) | 5–10 years | 215 (54.3%) | 21 (5.3%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 57 (14.4%) | 35 (8.8%) | ||||
I do not have time to discuss patient-related medicine issues with clinicians | B/M Pharm | 87 (22%) | 0 (0%) | 0.000* | State funded | 157 (39.6%) | 42 (10.6%) | 0.004 | < 5 years | 55 (13.9%) | 13 (3.3%) | 0.000* |
Pharm.D | 232 (58.6%) | 63 (15.9%) | Private | 176 (44.4%) | 21 (5.3%) | 5–10 years | 187 (47.2%) | 49 (12.4%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 91 (23.0%) | 1 (0.3%) | ||||
I feel inadequately trained to deal with clinicians on clinical medicine-related issues on behalf of patients | B/M Pharm | 87 (22%) | 0 (0%) | 0.000* | State funded | 193 (48.7%) | 6 (1.5%) | 0.000* | < 5 years | 59 (14.9%) | 9 (2.3%) | 0.055 |
Pharm.D | 245 (61.9%) | 50 (12.6%) | Private | 153 (38.6%) | 44 (11.1%) | 5–10 years | 200 (50.5%) | 36 (9.1%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 87 (22.0%) | 5 (1.3%) | ||||
I have sufficient confidence in my clinical knowledge to provide this service | B/M Pharm | 87 (22.0%) | 0 (0%) | 0.000* | State funded | 191 (48.2%) | 8 (2.0%) | 0.000* | < 5 years | 50 (12.6%) | 18 (4.5%) | 0.000* |
Pharm.D | 208 (52.5) | 87 (22%) | Private | 118 (29.8%) | 79 (19.9%) | 5–10 years | 170 (42.9%) | 66 (16.7%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 89 (22.5%) | 3 (0.8%) | ||||
Patients will get conflicting information regarding medicines use if pharmacists develop their medicines management services | B/M Pharm | 39 (9.8%) | 48 (12.1%) | 0.000* | State funded | 77 (19.4%) | 122 (30.8%) | 0.585 | < 5 years | 19 (4.8%) | 49 (12.4%) | 0.009 |
Pharm.D | 95 (24%) | 200 (50.5%) | Private | 71 (17.9%) | 126 (31.8%) | 5–10 years | 83 (21.0%) | 153 (38.6%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 46 (11.6%) | 46 (11.6%) | ||||
Enhanced clinical input will further develop my current relationship with clinicians | B/M Pharm | 51 (12.9%) | 36 (9.1%) | 0.000* | State funded | 162 (40.9%) | 37 (9.3%) | 0.001 | < 5 years | 66 (16.7%) | 2 (0.5%) | 0.000* |
Pharm.D | 280 (70.7%) | 15 (3.8%) | Private | 183 (46.2%) | 14 (3.5%) | 5–10 years | 219 (55.3%) | 17 (4.3%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 60 (15.2%) | 32 (8.1%) |